Japan’s Generic Drug Market 2019-2024: Japan Has One of the Lowest Penetration of Generics – ResearchAndMarkets.com
April 15, 2019DUBLIN–(BUSINESS WIRE)–The “Japan
Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s
offering.
The report represents an in-depth analysis on the historical, current
and future market trends in the generic drug market in Japan. This
research report serves as an exceptional tool to understand the drivers,
sales trends, prescription trends, market structure, competitive
landscape, regulations, key players, key drugs, manufacturing and the
outlook of generic drug market in Japan.
Japan represents the world’s eighth biggest market for generic drugs in
terms of value. Generic drugs, however, have traditionally enjoyed a
relatively lower penetration in Japan compared to other developed
markets such as the United States and Europe.
Historically, the lower penetration of generic drugs in japan was due to
several reasons. These included – the perception of inferior quality of
generic drugs, the preference of branded drugs among physicians and
patients and the limited profits to be made by physicians from
pharmaceutical price differentials by prescribing low priced generics.
Generic drugs also remained less popular in Japan because of the lack of
generic substitution rights by Japanese pharmacists, slower review times
in the drug approval process and difficulties working with major
pharmaceutical distributors – many of whom were closely tied to major
branded drug manufacturers.
The landscape of the japan generic drug market, however, has changed
noticeably over the last decade. The Japanese government has identified
growth of the country’s generic drug market as imperative to Japan’s
long-term economic health. The Japanese government, recognizing the
country’s increasing aging population as well as rising costs of branded
drugs has begun instituting healthcare policy changes to cut their
expenditures on medical costs.
Drug costs account for around a fifth of the country’s total medical
expenses and reducing this burden has become a cornerstone of Japan’s
health administration policy. Substitution of low-cost generic drugs for
innovator products has been identified as a strategy where major savings
are possible. Driven by these initiatives, the penetration of generics
has grown robustly over the past few years.
The government has also made a target towards achieving a generic
penetration of 60% by 2018. This is expected to create huge
opportunities for both domestic and foreign generic manufacturers in
Japan.
Key Questions Answered
- What are generic drugs? How are they different from branded drugs?
- How has Japan’s generic drug market performed in recent years?
- How have generic drugs performed compared to branded drugs?
- What were the total sales and prescriptions for generic drugs in Japan?
-
Who are the key players in the Japanese generic drug market? How have
they performed? - What is the structure of the Japanese generic drug market?
- What is the pricing mechanism of generic drugs in Japan?
- What is the value chain of generic drugs in Japan?
- What are the regulations for generic drugs in Japan?
- How are generic drugs distributed in Japan?
- How are generic drugs manufactured?
-
What are the raw material and machinery requirements to manufacture
generic drugs? -
What are the drivers and challenges in the Japanese generic drug
market?
Topics Covered
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Generic Drug Market – Introduction
4.1 What are Generic Drugs?
4.2 Unbranded and Branded Generic Drugs
4.3 Authorized Generic Drugs
5 Why is the Japanese Generic Drug Market So Lucrative?
5.1 Blockbuster Drugs Going Off-Patent
5.2 Rising Healthcare Costs Coupled with an Increasing Ageing Population
5.3 Japan Has One of the Lowest Penetration of Generics
5.4 Incentives for Dispensing Generics
5.5 Significant Savings for Payers & Providers
5.6 Biosimilars
6 Global Generic Drug Market
6.1 Market Performance
6.2 Market Breakup by Country
6.3 Market Forecast
6.4 Most Prescribed Generic and Branded Drugs
7 Japan Generic Drug Market
7.1 Japan Pharmaceutical Market Performance
7.2 Japan Generic Drug Market Performance
8 SWOT Analysis
8.1 Overview
8.2 Strength
8.3 Weakness
8.4 Opportunities
8.5 Threats
9 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
10 Porter’s Five Forces Analysis
10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes
11 Japan Generic Drug Market – Competitive Landscape
11.1 Japan Generic Drug Market – Competitive Structure
11.2 Japan Generic Drug Market – Breakup by Key Players
11.3 Japan Generic Drug Market – Breakup by Distribution Channel
12 Japan Generic Drug Market- Value Chain Analysis
12.1 Research and Development
12.2 Manufacturing
12.3 Marketing
12.4 Distribution
13 Regulations in Japan Generics Industry
13.1 Approval Pathway of a Generic Drug in Japan
13.2 Certifications
14 Japan Generic Drug Market: Key Success Factors
15 Japan Generic Drug Market: Road Blocks
16 Requirements for Setting up a Generic Drug Manufacturing Plant
16.1 Manufacturing Process
16.2 Raw Material Requirements
16.3 Raw Material Pictures
16.4 Land and Construction Requirements
16.5 Machinery and Infrastructure Requirements
16.6 Machinery Pictures
16.7 Plant Layout
16.8 Packaging Requirements
16.9 Utility Requirements
16.10 Manpower Requirements
17 Japan Generic Drug Market – Key Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/wz1hvi
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Generic
Drugs
